Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of 100 microgram starting dose wasp venom immunotherapy
NL-OMON38607Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- May 2013
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Trial of Pharmalgen Vespula spp in wasp sting hypersensitivity and insect sting allergy, sponsored by University Medical Center Groningen. Started May 2013; status: active, not recruiting.
02
Drugs
Pharmalgen Vespula spp.
03
Conditions
wasp sting hypersensitivityinsect sting allergy
Beyond the preview
Go deeper on NL-OMON38607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38607.